TC BioPharm (Holdings) PLC (TCBP)
1.92
+0.46
(+31.51%)
USD |
NASDAQ |
May 06, 12:06
TC BioPharm Total Assets (Quarterly): 11.38M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.38M |
| June 30, 2023 | 10.38M |
| December 31, 2022 | 13.67M |
| June 30, 2022 | 16.46M |
| Date | Value |
|---|---|
| December 31, 2021 | 10.83M |
| September 30, 2021 | 9.585M |
| December 31, 2020 | 9.903M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.585M
Minimum
Sep 2021
16.46M
Maximum
Jun 2022
11.74M
Average
10.83M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 282.62M |
| Biodexa Pharmaceuticals Plc | 13.43M |
| NuCana PLC | 35.43M |
| Autolus Therapeutics PLC | 375.38M |
| Mereo BioPharma Group PLC | 66.50M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.957M |
| Shareholders Equity (Quarterly) | 3.421M |